Kratom

FDA Concerned About Potential for Abuse, Addiction With Kratom

FDA Concerned About Potential for Abuse, Addiction With Kratom

By

An investigation of the 25 most prevalent compounds in kratom showed that these compounds share structural similarities with controlled opioid analgesics, such as morphine derivatives.

FDA Expresses Safety Concern Over Kratom

FDA Expresses Safety Concern Over Kratom

By

The Food and Drug Administration's Commissioner Scott Gottlieb, MD, has issued a statement regarding the deadly risks associated with the botanical substance, kratom.

What the Scheduling of Kratom by the DEA Means for Research

What the Scheduling of Kratom by the DEA Means for Research

By

The DEA's plan to list kratom as a Schedule I controlled substance would make researching the possible opioid substitute much more difficult.

Sign Up for Free e-Newsletters